Engineering and Design of Chimeric Antigen Receptors

Engineering and Design of Chimeric Antigen Receptors

Blog Article

T cells engineered with chimeric antigen receptors (CARs) have emerged as a potent new class of therapeutics for cancer, based on their remarkable potency in blood cancers.Since the first clinical iphone 14 price texas reports of their efficacy emerged 7 years ago, investigators have focused on the mechanisms and properties that make CARs effective or toxic, and their effects on T cell biology.Novel socialstudiesscholar.com CAR designs coupled with improvements in gene transfer technology, incorporating advances in gene editing, have the potential to increase access to engineered cell therapies, as well as improve their potency in solid tumors.Keywords: CAR T cells, immunotherapy, chimeric antigen receptors, cancer.